Latest News
Latest News
  • Home
  • Video Shows
    VantageFirstpost AmericaFirstpost AfricaFirst Sports
  • World
    US News
  • Explainers
  • News
    IndiaOpinionCricketTechEntertainmentSportsHealthPhotostories
  • India vs Australia
TrendingDonald TrumpNarendra ModiElon MuskUnited StatesJoe Biden
Latest News

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Coronavirus Vaccine In India

Recent Highlights

Over 19.5L COVID-19 vaccinations, 348 AEFIs so far; Delhi heading to 'herd immunity', suggests sero-survey

Over 19.5L COVID-19 vaccinations, 348 AEFIs so far; Delhi heading to 'herd immunity', suggests sero-survey

.
COVID-19 vaccination: 3.81 lakh inoculated, 580 suffer adverse events; Delhi sees dip in turnout

COVID-19 vaccination: 3.81 lakh inoculated, 580 suffer adverse events; Delhi sees dip in turnout

.
Covaxin trials conducted with '200% honesty', says Bharat Biotech MD; new COVID-19 cases under 20,000 for 3rd day

Covaxin trials conducted with '200% honesty', says Bharat Biotech MD; new COVID-19 cases under 20,000 for 3rd day

.
India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III trials from Monday

India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III trials from Monday

.

All Stories for Coronavirus Vaccine In India

All (6)
  • Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan

    Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan

    Fp Staff • .

    Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials

  • COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

    COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

    Trendingdesk • .

    No process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given.

  • Home
  • coronavirus vaccine in india

About Firstpost

Most Searched Categories

  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025

NETWORK18 SITES

  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
youtube
youtube

is on YouTube

Subscribe Now

Copyright @ 2025. Firstpost - All Rights Reserved.

Contact Us Privacy Policy Cookie Policy Terms Of Use
HomeVideosShortsLive TV